Friend erythroleukaemia cell mutants defective in viral gene expression. 1984

J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura

Cellular mutants defective in the expression of viral polypeptides were isolated from the Friend erythroleukemia cell line 745a by immunoselection with anti-ecotropic murine leukaemia virus serum in the presence of complement. The mode of appearance of the antiserum-resistant cells showed an interesting pattern which is discussed in the text. One of the mutants obtained contained no detectable gp70 or p15(E) while retaining gPr90env; defects appeared to reside in the processing of the gPr90env to gp70 and p15(E). In another type of mutant, gPr90env was not detected. All these mutants retained spleen focus-forming virus (SFFV)-specific gp55 and gag precursor Pr68gag. The mutants superinfected with the helper virus produced the helper and SFFV also, indicating that these mutations did not affect the replication of the exogenously infecting virus.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005622 Friend murine leukemia virus A strain of Murine leukemia virus (LEUKEMIA VIRUS, MURINE) producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice. Friend Virus,Rowson-Parr Virus,Rowson Parr Virus,Virus, Friend,Virus, Rowson-Parr
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014759 Viral Envelope Proteins Integral membrane proteins that are incorporated into the VIRAL ENVELOPE. They are glycosylated during VIRAL ASSEMBLY. Envelope Proteins, Viral,Viral Envelope Glycoproteins,Viral Envelope Protein,Virus Envelope Protein,Virus Peplomer Proteins,Bovine Leukemia Virus Glycoprotein gp51,Hepatitis Virus (MHV) Glycoprotein E2,LaCrosse Virus Envelope Glycoprotein G1,Simian Sarcoma Virus Glycoprotein 70,Viral Envelope Glycoprotein gPr90 (Murine Leukemia Virus),Viral Envelope Glycoprotein gp55 (Friend Virus),Viral Envelope Proteins E1,Viral Envelope Proteins E2,Viral Envelope Proteins gp52,Viral Envelope Proteins gp70,Virus Envelope Proteins,Envelope Glycoproteins, Viral,Envelope Protein, Viral,Envelope Protein, Virus,Envelope Proteins, Virus,Glycoproteins, Viral Envelope,Peplomer Proteins, Virus,Protein, Viral Envelope,Protein, Virus Envelope,Proteins, Viral Envelope,Proteins, Virus Envelope,Proteins, Virus Peplomer

Related Publications

J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
June 1989, Cell biology international reports,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
January 2002, Folia biologica,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
December 1997, British journal of haematology,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
October 1987, Mutation research,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
August 1994, Biochimica et biophysica acta,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
November 1987, Cell biology international reports,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
April 1982, Nature,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
January 1992, Cancer surveys,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
January 1980, Cold Spring Harbor symposia on quantitative biology,
J Yokota, and A Iwamoto, and A Suzuki, and S Yamaguchi-Tejima, and Y Kitamura, and H Yoshikura
November 1988, Journal of virology,
Copied contents to your clipboard!